Use of benzodiazepines in social anxiety disorder, generalized anxiety disorder, and posttraumatic stress disorder

Journal of Clinical Psychiatry

Volumn 65, Issue SUPPL. 5, 2004, Pages 29-33

  Davidson, Jonathan R T ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY DISORDER; HUMAN; PHOBIA; POSTTRAUMATIC STRESS DISORDER; REVIEW;

ANXIETY DISORDERS; HUMANS; PHOBIC DISORDERS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 3843098474     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Hidalgo RB, Barnett SD, Davidson JR. Social anxiety disorder in review: two decades of progress. Int J Neuropsychopharmacol 2001;4:279-298
2. Davidson JR, Ford SM, Smith RD. Long-term treatment of social phobia with clonazepam. J Clin Psychiatry 1991;52(suppl 11):16-20
3. Gelernter CS, Uhde TW, Cimbolic P, et al. Cognitive-behavioral and pharmacological treatments of social phobia: a controlled study. Arch Gen Psychiatry 1991;48:938-945
4. Reiter SR, Pollack MH, Rosenbaum JF, et al. Clonazepam for the treatment of social phobia. J Clin Psychiatry 1990;51:470-472
5. Versiani M, Nardi A, Figueira L, et al. Double-blind placebo controlled trial with bromazepam in social phobia. J Bras Psiquiatr 1997;46:167-171
6. Reich J, Noyes R Jr, Yates W. Alprazolam treatment of avoidant personality traits in social phobic patients. J Clin Psychiatry 1989;50:91-95
7. Davidson JR, Tupler LA, Potts NLS. Treatment of social phobia with benzodiazepines. J Clin Psychiatry 1994;55(suppl 6):28-32
8. Munjack DJ, Baltazar PL, Bohn PB, et al. Clonazepam in the treatment of social phobia: a pilot study. J Clin Psychiatry 1990;51(suppl 5):35-40
9. Davidson JR, Potts N, Richichi E, et al. Treatment of social phobia with clonazepam and placebo. J Clin Psychopharmacol 1993;13:423-428
10. Sutherland SM, Tupler LA, Colket JT, et al. A 2 year follow-up of social phobia: status after a brief medication trial. J Nerv Ment Dis 1996;184:731-738
11. Connor KM, Davidson JR, Potts NL, et al. Discontinuation of clonazepam in the treatment of social phobia. J Clin Psychopharmacol 1998;18:373-378
12. Lydiard RB, Ballenger JC, Rickels K, for the Abecarnil Work Group. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. J Clin Psychiatry 1997;58(suppl 11):11-18
13. Rickels K, Downing R, Schweizer E, et al. Antidepressants for the treatment of generalized anxiety disorder: a placebo-controlled comparison of imipramine, trazodone, and diazepam. Arch Gen Psychiatry 1993;50:884-895
14. Rocca P, Fonzo V, Scotta M, et al. Paroxetine efficacy in the treatment of generalized anxiety disorder. Acta Psychiatr Scand 1997;95:444-450
15. Klein E, Colin V, Stolk J, et al. Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine. Am J Psychiatry 1994;151:1760-1766
16. Gelpin E, Bonne O, Peri T, et al. Treatment of recent trauma survivors with benzodiazepines: a prospective study. J Clin Psychiatry 1996;57:390-394
17. Mellman TA, Bustamante V, David D. Hypnotic medication in the aftermath of trauma [letter]. J Clin Psychiatry 2002;63:1183-1184
18. Risse SC, Whitters A, Burke J. Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat-induced posttraumatic stress disorder. J Clin Psychiatry 1990;51:206-209